Physician profile
Stephen Carveth
NPI 1225558638
$17,064.62
in general payments reported to CMS, 2019-2025
11 companies · $76.90 in 2025
The $76.90 reported for 2025 was less than what a typical Pediatric Orthopaedic Surgery provider received nationally (typical 2025 total: $271).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $389 · 2020: $375 · 2021: $321 · 2022: $16K · 2023: $53.94 · 2024: $61.63 · 2025: $76.90.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $192.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $192.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $15,000.00 | 2022 | |
| Medical Device Business Services, INC. | $1,083.32 | 2019-2022 | |
| Depuy Synthes Sales INC. | $295.05 | 2021-2024 | Va-Lcp, Na |
| Orthopediatrics Corp. | $212.75 | 2022-2025 | |
| Zimvie INC. | $188.20 | 2022 | |
| Medwest Associates | $88.53 | 2020-2022 | |
| Stryker Corporation | $72.03 | 2021-2024 | Iconix, Air |
| Zimmer Biomet Holdings, INC. | $70.08 | 2019 | |
| Wright Medical Technology, INC. | $24.66 | 2019 | |
| Vericel Corporation | $19.01 | 2023 | Maci |
| Pfizer INC. | $10.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Carveth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.